Copy number analysis performed on six selected CRC tumors including those immunolabeled by anti-POFUT1 revealed an increase of POFUT1 copy number in five patients with in majority of cases between 2 and 3 copies, like in bioinformatics analysis (Figure 3D). This evidence concerns the gene POFUT1 and colorectal carcinoma.